GOP takes aim at Gregg over legislative health care perk
Indiana Republicans are criticizing Democratic gubernatorial nominee John Gregg for a lucrative perk he helped institute for members of the General Assembly when he was speaker of the House.
Health Care
Articles
New Indiana law allows virtual doctor’s visits
A new law that lets residents visit with health care professionals via smartphones has gone into effect in Indiana.
Fun with numbers: Plug in a city, see the cost of long-term care
It’s not as fun as planning a vacation or shopping for a motorcycle, but these are numbers you’re probably going to need.
Riley Hospital steps up statewide push
New President Matthew Cook’s job is to build out a system that will help get physician referrals across the state to help fill Riley’s 385 beds.
Federal judge blocks Indiana abortion law before deadline
A federal judge blocked a new Indiana law Thursday that bans abortions sought because of a fetus' genetic abnormalities or because of its race, sex or ancestry. The law was to take effect Friday.
Lilly stock rises after FDA panel backs new Jardiance label
A hot-selling drug for diabetes sold by Eli Lilly and Co. and a co-partner just got another potential boost, as a government panel narrowly recommended that the companies should be allowed to claim that the drug cuts the risk of cardiovascular death.
Embattled ITT winds down nursing program at 3 Indiana campuses
The state warned the institution about low passing rates earlier this year and asked for a “plan of correction”—the first step that could lead to a loss of state accreditation.
Anthem faces showdown with antitrust cops in bid for Cigna
The health insurers are set to meet Friday with the Justice Department’s No. 3 official, a critical moment as the government makes its decision about whether to approve or block the $48 billion deal.
CEO Ellis resigns after 20 years at struggling drug firm Endocyte
The West Lafayette-based company has named CFO and COO Mike Sherman as new CEO and president, but did not give a reason for the abrupt change in leadership.
More jitters over the Anthem-Cigna deal
Federal regulators are giving the proposed $48 billion merger between health insurers Anthem Inc. and Cigna Corp a hard look, and some analysts are hedging their bets.
Study: Docs who get free meals pick branded drugs more
Doctors who accept free meals from the pharmaceutical industry are more likely to prescribe certain branded drugs to Medicare patients than generics, according to a study published Monday.
IU to hire 40 faculty, spend up to $120M on new initiative
The money will be awarded from IU’s Grand Challenges Program, a new push that is designed to tackle “major and large-scale problems facing humanity” that can only be addressed by multidisciplinary research teams.
Device lawsuits plague Cook Medical
The lawsuits against Cook Medical began four years ago with a trickle but have since turned into a gusher, now surpassing 500.
Biotech firm lands funding for cancer targeting
Animated Dynamics Inc. has raised $1.7 million in early funding to help it get its technology to market.
Troubled home health care provider Nightingale to sell itself
One of Indiana’s largest home health care providers, facing allegations that it put patients in immediate jeopardy, has agreed to be acquired by a competing company in a deal that could be worth as much as $3 million.
Merck, Pfizer double size of diabetes drug study to catch rivals
The competition heated up in the $71.5 billion global diabetes market last year after Indianapolis-based Eli Lilly’s and Boehringer Ingelheim’s Jardiance unexpectedly reduced the risk of heart attacks, strokes and deaths in a study.
Indiana sees 70 percent surge in syphilis cases
State health officials are urging Indiana's health care providers to aggressively test patients for syphilis.
Medicaid cuts spell trouble for home health firms
The state’s Family and Social Services Administration is set to cut home health care Medicaid reimbursements for licensed practical nurses, registered nurses, aides, therapists and pathologists.
Biochemist Richard DiMarchi is ‘true entrepreneur’
Biochemist has founded or co-founded five startups since retiring from Eli Lilly and Co. as head of biotechnology research 13 years ago, at age 50.
CEO Lechleiter says Lilly in ‘most prolific period of new launches’
The Indianapolis-based drugmaker said Tuesday it has built a robust pipeline of drugs that “has the potential” to launch 20 new products in the 10 years between 2014 and 2023.